New research sheds light on role of HPV in head and neck cancers

October 7, 2016, University College London
Human Papillomavirus. Credit: Wikimedia Commons

Human Papillomavirus (HPV) drives a greater number of head and neck cancers than previously thought, finds new research from UCL and the University of Southampton.

The findings, published in the Journal of Clinical Oncology, offer valuable insight into the role of HPV in tumour development and explore the possibility of a viable treatment option for specific cancer patients.

HPV affects the skin and the moist membranes that line parts of the body. There are over 100 different types of the virus and the body's immune system is normally able to get rid of an HPV infection without it causing any problems. However,some HPV types are known to cause specific cancers, in particular cervical cancer and tonsil cancers (oropharyngeal cancers).

It is known that in HPV associated (HPV+) oropharyngeal cancer, there's a very strong link between the number of immune cells (T-cells) in the tumour and patient survival - when high numbers of T-cells are present, patients respond well to therapy (either surgery or chemoradiotherpay). When tumours are not caused by the virus (HPV-), far fewer immune cells are present, and patients do not respond as well to treatment. This suggests that the cancers caused by virus are more readily detected by the patients' immune systems, and this intrinsic immune response plays a key role in the better survival of most patients with HPV+ cancers.

So, when the team discovered that HPV was also driving a small percentage of head and neck cancers at sites other than the oropharynx, it seemed likely that these patients would also experience significantly better survival rates. Surprisingly this was not the case.

"When we looked at HPV+ cancers at other head and neck sites, we didn't see the same survival benefit or infiltration of T-cells as we did in the HPV+ tonsil cancers." explains Dr Tim Fenton, Senior Research Associate, UCL Cancer Institute, and senior author of the study. "And we think that this is the major difference in determining the difference in patient prognosis."

So why is there such a marked difference in immune cell numbers in HPV+ oropharyngeal cancer and HPV+ cancers at other sites in the head and neck? The answer may lie in the anatomy of the oropharynx (tonsils).

Dr Fenton says "The tonsils are composed of lymphoid tissue, so there are many already present in this area. There's a possibility that cancers developing in the tonsils are very visible to the immune system in that respect. However, HPV- oropharyngeal cancers contain far fewer T-cells, so it appears to be a combination of having a virally driven cancer that is located in the tonsil that gives a strong immune response, and much better clinical outcome."

"The other important point to take from this study, is that there are HPV-targeted therapeutic vaccines in clinical trials at the moment. In fact the Southampton team are about to open a clinical trial testing one such vaccine (HARE-40 Trial) . Currently, we test oropharyngeal cancers for HPV, but not cancers arising at other sites in the head and neck. Even though numbers of these patients are relatively small - approximately 1 in 25 patients - the likely benefit from vaccination, particularly as these treatments become more fully developed, means that testing should be more widespread for these specific cancers."

Explore further: Incisionless robotic surgery offers promising outcomes for oropharyngeal cancer patients

More information: A. Chakravarthy et al. Human Papillomavirus Drives Tumor Development Throughout the Head and Neck: Improved Prognosis Is Associated With an Immune Response Largely Restricted to the Oropharynx, Journal of Clinical Oncology (2016). DOI: 10.1200/JCO.2016.68.2955

Related Stories

Incisionless robotic surgery offers promising outcomes for oropharyngeal cancer patients

September 16, 2016
A new study from researchers at Henry Ford Hospital finds an incisionless robotic surgery – done alone or in conjunction with chemotherapy or radiation – may offer oropharyngeal cancer patients good outcomes and survival, ...

Particular HPV strain linked to improved prognosis for throat cancer

September 28, 2016
When it comes to cancer-causing viruses like human papillomavirus, or HPV, researchers are continuing to find that infection with one strain may be better than another.

Study examines link between HPV and risk of head and neck cancers

January 21, 2016
Researchers at Albert Einstein College of Medicine have found that when human papillomavirus (HPV)-16 is detected in peoples' mouths, they are 22 times more likely than those without HPV-16 to develop a type of head and neck ...

Prognosis of tumors positive for human papilloma virus in head and neck cancers varies according to the site

April 6, 2014
Patients with cancer of the throat and who are positive for the Human Papilloma virus (HPV+) have a good prognosis, but until now the effect of being HPV+ on the prognosis of tumours located elsewhere in the head and neck ...

People with hepatitis C are two to five times more likely to develop certain head and neck cancers

April 13, 2016
Long associated with liver cancer and non-Hodgkin's lymphoma, a study from The University of Texas MD Anderson Cancer Center reveals for the first time that the hepatitis C virus (HCV) is associated with certain head and ...

Recommended for you

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

Researchers develop swallowable test to detect pre-cancerous Barrett's esophagus

January 17, 2018
Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test for early detection of Barrett's esophagus that offers promise ...

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.